A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

PHASE4CompletedINTERVENTIONAL
Enrollment

1,711

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Postmenopausal Osteoporosis
Interventions
DRUG

Ibandronate

Film-coated oral ibandronate tablet (150 mg) once-monthly

Trial Locations (142)

10011

New York

11201

Brooklyn

13057

East Syracuse

14609

Rochester

14760

Olean

19004

Bala-Cynwyd

19047

Langhorne

19114

Philadelphia

19131

Philadelphia

19610

Wyomissing

19805

Wilmington

20817

Bethesda

21204

Baltimore

23226

Richmond

23294

Richmond

23502

Norfolk

27103

Winston-Salem

27609

Raleigh

27704

Durham

27705

Durham

28144

Salisbury

28304

Fayetteville

28401

Wilmington

28557

Morehead City

28655

Morganton

29307

Spartanburg

29425

Charleston

29464

Mt. Pleasant

30033

Decatur

30165

Rome

30309

Atlanta

30904

Augusta

32127

Port Orange

32605

Gainesville

32607

Gainesville

32720

DeLand

32779

Longwood

32901

Melbourne

32905

Palm Bay

33180

Aventura

33186

Miami

33409

West Palm Beach

33761

Clearwater

33916

Fort Myers

34239

Sarasota

34471

Ocala

34684

Palm Harbor

35051

Columbiana

35235

Birmingham

35801

Huntsville

36111

Montgomery

36608

Mobile

37130

Murfreesboro

37203

Nashville

37620

Bristol

37862

Sevierville

38103

Memphis

43213

Columbus

44122

Beachwood

44406

Canfield

45246

Cincinnati

47714

Evansville

48118

Chelsea

48202

Detroit

49085

Saint Joseph

53209

Milwaukee

53705

Madison

55318

Chaska

58103

Fargo

58201

Grand Forks

59101

Billings

61610

Creve Coeur

61615

Peoria

61820

Champaign

63110

St Louis

63117

St Louis

63128

St Louis

63141

St Louis

64108

Kansas City

64114

Kansas City

65109

Jefferson City

67005

Arkansas City

67114

Newton

67207

Wichita

68131

Omaha

70119

New Orleans

71457

Natchitoches

71603

Pine Bluff

72024

Carlisle

72120

Sherwood

72143

Searcy

72205

Little Rock

72401

Jonesboro

72756

Rogers

73112

Oklahoma City

74104

Tulsa

75010

Carrollton

75231

Dallas

76210

Denton

76309

Wichita Falls

78229

San Antonio

78414

Corpus Christi

80260

Lakewood

80909

Colorado Springs

83712

Boise

83814

Coeur d'Alene

85006

Phoenix

85014

Phoenix

85225

Chandler

85253

Paradise Valley

85282

Tempe

85295

Gilbert

85712

Tucson

90211

Beverly Hills

91361

Westlake Village

92083

Vista

92128

San Diego

92260

Palm Desert

92653

Laguna Hills

92691

Mission Viejo

92801

Anaheim

94304

Palo Alto

95825

Sacramento

97210

Portland

97504

Medford

98055

Renton

98105

Seattle

98144

Seattle

98405

Tacoma

Tacoma

99207

Spokane

06001

Avon

06416

Cromwell

06518

Hamden

06320

New London

06708

Waterbury

07012

Clifton

07748

Middletown

08901

New Brunswick

08540

Princeton

11794-8161

Stony Brook

23507-1912

Norfolk

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02604836 - A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia | Biotech Hunter | Biotech Hunter